# A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

> **NCT03866967** · PHASE2 · COMPLETED · sponsor: **Akeso** · enrollment: 130 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **BIOLOGICAL:** AK105

## Key facts

- **NCT ID:** NCT03866967
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-27
- **Primary completion:** 2021-03-13
- **Final completion:** 2024-03-22
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2025-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866967, "A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03866967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*